Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07215221 · ClinicalTrials.gov registry record · NA
Implementation of TBI-RECOVER in Substance Use Treatment
A NA study, sponsored by Ohio State University.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
NCT07215221: Recruiting NA study, sponsored by Ohio State University.
NCT07215221 is a NA study that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 900 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07215221, a NA study, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
Study Summary
The goal of this hybrid type 2 pilot trial is to understand the implementation and effectiveness of the TBI-RECOVER intervention model (e.g., brain injury screening, cognitive and behavioral challenges screening, and neurocognitive accommodations) on patient retention in outpatient substance use disorder treatment. We will evaluate whether an implementation strategy bundle (e.g., training/education, champions, audit \& feedback, facilitation) improves provider use and sustainability of the TBI-RECOVER intervention, and also whether the TBI-RECOVER intervention improves patient symptoms and treatment retention.
Primary Outcome
The proportion of treatment sessions attended over one year.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL TBI-RECOVER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2026-04-28 |
| Est. Completion | 2030-03-30 |
| Phase | NA |
What NCT07215221 shows while recruiting
NCT07215221 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT07215221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07215221 about?
NCT07215221 is a clinical study titled "Implementation of TBI-RECOVER in Substance Use Treatment". The goal of this hybrid type 2 pilot trial is to understand the implementation and effectiveness of the TBI-RECOVER intervention model (e.g., brain injury screening, cognitive and behavioral challenges screening, and neurocognitive accommodations) on patient retention in outpatient substance use dis...
What is the current status of trial NCT07215221?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2026-04-28. Estimated completion is 2030-03-30.
What interventions are being tested in trial NCT07215221?
The interventions under investigation include: Control (BEHAVIORAL), TBI-RECOVER (BEHAVIORAL).
Who is sponsoring clinical trial NCT07215221?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07215221's enrollment target sits among peer trials
900 124th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI